Cargando…
Plasma FGF21 Levels Are Not Associated with Weight Loss or Improvements in Metabolic Health Markers upon 12 Weeks of Energy Restriction: Secondary Analysis of an RCT
Recent studies suggest that circulating fibroblast growth factor 21 (FGF21) may be a marker of metabolic health status. We performed a secondary analysis of a 12-week randomized controlled trial to investigate the effects of two energy restriction (ER) diets on fasting and postprandial plasma FGF21...
Autores principales: | Gijbels, Anouk, Schutte, Sophie, Esser, Diederik, Michielsen, Charlotte C. J. R., Siebelink, Els, Mars, Monica, Mensink, Marco, Afman, Lydia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735516/ https://www.ncbi.nlm.nih.gov/pubmed/36501091 http://dx.doi.org/10.3390/nu14235061 |
Ejemplares similares
-
Diverging metabolic effects of 2 energy-restricted diets differing in nutrient quality: a 12-week randomized controlled trial in subjects with abdominal obesity
por: Schutte, Sophie, et al.
Publicado: (2022) -
Effects of a 12-Week Whole-Grain or Refined Wheat Intervention on Plasma Acylcarnitines, Bile Acids, and Signaling Lipids and Association With Liver Fat
por: Gijbels, Anouk, et al.
Publicado: (2022) -
Effects of a 12-week whole-grain or refined wheat intervention on plasma acylcarnitines, bile acids and signaling lipids, and association with liver fat: A post-hoc metabolomics study of a randomized controlled trial
por: Gijbels, Anouk, et al.
Publicado: (2022) -
Minor Changes in the Composition and Function of the Gut Microbiota During a 12-Week Whole Grain Wheat or Refined Wheat Intervention Correlate with Liver Fat in Overweight and Obese Adults
por: van Trijp, Mara P H, et al.
Publicado: (2020) -
Responses to High-Fat Challenges Varying in Fat Type in Subjects with Different Metabolic Risk Phenotypes: A Randomized Trial
por: van Dijk, Susan J., et al.
Publicado: (2012)